jyoung
09-21-2009, 11:22 PM
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) is amongst the top percentage gainers in the early morning trade. The stock shot up 16.25% or $0.23 to $1.43 and is trading with a huge volume of 1.83 million shares compared to a daily average of 89k shares. Today September 21, 2009 AEterna Zentaris Inc. announced the completion of a Phase I study of its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer……………
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!